Novel Therapeutic Approaches of Rare Genetic and Haematological Diseases

Takeda Pharmaceutical are launching an open innovation initiative inviting researchers to submit their proposals addressing novel therapeutic approaches related to rare diseases, specifically rare genetic and rare haematological diseases. One‑year projects will be funded up to JPY 10,000,000 or equivalent amount, including indirect costs.

Projects should address the following area:

REF#5 Novel therapeutic approaches for lysosomal storage disorders, inborn errors of metabolism (liver metabolic and neurometabolic) and rare non-malignant haematological diseases...